| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Osteoporosis | |||||
| Cerebral Palsy | |||||
| Spina Bifida | |||||
| Osteopenia | |||||
| Osteogenesis Imperfecta | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Bone Diseases, Metabolic | |||||
| Spinal Dysraphism | |||||
| 3 | More general conditions related to this trial | ||||
| Bone Diseases | |||||
| Bone Diseases, Developmental | |||||
| Brain Damage, Chronic | |||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Collagen Diseases | |||||
| Congenital Abnormalities | |||||
| Connective Tissue Diseases | |||||
| Genetic Diseases, Inborn | |||||
| Musculoskeletal Diseases | |||||
| Nervous System Diseases | |||||
| Nervous System Malformations | |||||
| Neural Tube Defects | |||||
| Osteochondrodysplasias | |||||
| 4 | Interventions listed in this trial | ||||
| pamidronate | |||||
| saline | |||||
| 5 | More general drug interventions related to this trial | ||||
| Bone Density Conservation Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| 6 | Sponsors listed in this trial | ||||
| University of New Mexico | |||||
| Thrasher Foundation | |||||
|
